Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Todos Med Ltd. (TOMDF) Message Board

The Long Covid is a huge challenge that is not goi

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 1418
(Total Views: 245)
Posted On: 04/28/2022 10:33:39 AM
Avatar
Posted By: redspeed
The Long Covid is a huge challenge that is not going to be easily solved. So much is unknown. I'm sure a number of them have tried many things only to feel beyond frustration and at this point, highly skeptical of anything and everything. Especially something that cost money. A couple of tweets isn't going to change that.

I would not waste my time trying to convince a few (0.0001%) to try something else. Focus on those that want to and let them speak to their outcomes as they likely will be very vocal with even just some success, within their own communities. Even better yet, through their doctors.

If I was a Long Hauler, I'd read up on 3cl protease inhibitors and then decide if I want to discuss with my doctor and potentially join a study. Much more productive than debating on twitter with the hardened skeptics. I do get, better to be a skeptic in the sense you narrow down the best choices rather than trying anything and everything. Give them the tools to accelerate their learning. Teach them were to fish, rather than trying to sell them grouper sandwiches.

It does remind me if iLie though. You got those that actually tried the product and knows it works and then you have others that spend all day and night warning people, not because the product doesn't work, but they don't like someone.

At this point, we don't know if Tollovid would help 1% or 100% of sufferers. Too early, but would be great if some. Wasn't the focus of Todos anyway, but they are trying to help. Point people to join the study and if they can't wait or feel like trying Tollovid sooner then go ahead. The price was dropped for the next month for them.

Todos Medical Reports 2nd Long COVID Case Study and Launches Website for Physicians and Pediatricians to Indicate Interest in Participating in Tollovid Long COVID Clinical Study - April 20, 2022

https://investor.todosmedical.com/news-events...-study-and

Here's the form...
https://todosmedical.com/long-covid-physicians-case-study





(1)
(0)




Todos Med Ltd. (TOMDF) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us